[Lc-Msn Analysis of Metabolites of 1,2-[Bis (1,2-Benzisoselenazolone-3(2h)-ketone)]-ethane, a Novel Anti-Cancer Agent in Rat].

Hai-Yan Zhou,Zhi-Yun Meng,Gui-Fang Dou,Jin-Lan Ma,Ya-Qing Lou,Guo-Liang Zhang
DOI: https://doi.org/10.16438/j.0513-4870.2010.05.015
2010-01-01
Abstract:This study is to elucidate the metabolic pathway of 1,2-[bis (1,2-benzisoselenazolone-3 (2H)-ketone)]-ethane (BBSKE) in rats. Rats were administrated with a single dose of BBSKE 200 mg x kg(-1). The metabolites in rat urine, feces, bile and plasma were identified by LC-MSn analysis. The characterization of fragment ions from LC-MSn chromatography and mass spectrometry was applied to the investigation of structures of metabolites. Three phase I metabolites were detected in rat urine and feces. Two of them were also found in plasma and one existed in bile. These products were derived from oxidized, methylated and S-methylated BBSKE, separately. One phase II glucuronide of BBSKE was also found in bile. Therefore, it is possible that BBSKE was metabolized by oxidization, methylation and glucuronidation.
What problem does this paper attempt to address?